SANA

Sana Biotechnology Inc

NASDAQ: SANA · HEALTHCARE · BIOTECHNOLOGY

$2.96

-3.90% today

Updated 2026-09-24

Market cap

$996.87M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.81

Dividend yield

—

52W range

$3 – $7

Volume

3.1M

Market cap

$996.87M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.81

Dividend yield

—

52W range

$3 – $7

Volume

3.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

4.0

Quality

3.0

Profitability

5.0

Valuation

C+

1/9

Piotroski F-Score

Weak

-7.6

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →260 stocks currently score above 75

Price targets

Analyst target

$8.43

+184.80%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

2 Strong Buy6 Buy1 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

+ Debt/equity 0.48x — low leverage

Risks

- Piotroski 1/9 — weak financial health

- Altman Z -7.56 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-34.41M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-266.39M	$-283.25M	$-266.76M	$-244.17M	$-63.63M
EPS	—	—	—	—	$-0.81
Free cash flow	$-310.93M	$-273.61M	$-256.58M	$-144.77M	$-34.41M
Profit margin	—	—	—	—	—

Recent insider activity

Date	Insider	Type	Shares	Price
2026-08-27	PATEL, DHAVALKUMAR DHIRAJLAL	Sale	41,158	$4.11
2026-08-26	PATEL, DHAVALKUMAR DHIRAJLAL	Sale	125,000	—
2026-08-26	PATEL, DHAVALKUMAR DHIRAJLAL	Buy	125,000	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
SANA	$996.87M	23	4.3	3.0	5.0	4.0	—	Avoid
LLY	$1.03T	76	9.3	10.0	5.0	6.0	—	Strong Buy
JNJ	$648.67B	59	4.7	8.5	3.7	5.5	—	Buy
ABBV	$454.36B	73	6.7	8.5	4.0	5.0	-73.51%	Strong Buy
MRK	$365.34B	36	4.0	4.5	2.0	5.0	-78.20%	Hold
UNH	$333.27B	62	7.3	5.5	5.3	5.5	-14.85%	Buy

Smart narrative

Sana Biotechnology Inc trades at $2.96. Our Smart Value Score of 23/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of -7.56, it sits in the distress.

Frequently asked questions

What is Sana Biotechnology Inc's stock price?

Sana Biotechnology Inc (SANA) trades at $2.96.

Is Sana Biotechnology Inc overvalued?

Sana Biotechnology Inc carries a Smart Value Score of 23/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Sana Biotechnology Inc (SANA)?

The 12-month analyst consensus target is $8.43, about 184.8% above the current $2.96. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Altman Z-Score?

Sana Biotechnology Inc's Altman Z-Score is -7.56, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-137.04%

Beta2.13

50D MA$3.48

200D MA$3.67

Shares out0.30B

Float0.19B

Short ratio—

Avg volume3.1M

Performance

1 week+14.04%

1 month-11.90%

3 months+1.52%

YTD-18.18%

1 year+2.15%

3 years—

5 years—

Compare

SANA vs LLY →SANA vs JNJ →SANA vs ABBV →Stock screener →